Views and Preferences of Medical Professionals and Pregnant Women About a Novel Primary Prevention Intervention for Hypertensive Disorders of Pregnancy: a Qualitative Study

Overview

Journal Reprod Health

Publisher Biomed Central

Specialty Reproductive Medicine

Date 2019 May 4

PMID 31046778

Citations 7

Authors

A Vestering

M N Bekker

D E Grobbee

R van der Graaf

A Franx

N M T Crombag

J L Browne

Affiliations

Soon will be listed here.

Abstract

Background: Calcium and low-dose aspirin are two potential approaches for primary prevention of hypertensive disorders of pregnancy (HDP). This study aimed to explore the acceptability, views and preferences of pregnant women and primary healthcare providers for a fixed-dose combined preparation of aspirin and calcium (a polypill) as primary prevention of HDP in an unselected pregnant population.

Methods: In this qualitative study eight in-depth semi-structured interviews were conducted with Dutch primary care midwives and general practitioners. Seven focus group discussions were organised with women with low-risk pregnancies. Topics discussed were: perceptions of preeclampsia; information provision about preeclampsia and a polypill; views on the polypill concept; preferences and needs regarding implementation of a polypill. Thematic analysis of the data transcripts was carried out to identify emerging themes.

Results: Two major themes shaped medical professionals' and women's views on the polypill concept: 'Informed Choice' and 'Medicalisation'. Both could be divided into subthemes related to information provision, personal choice and discussions with regard to the balance between 'unnecessary medicalisation' and 'scientific progress'.

Conclusions: In general, women and healthcare practitioners expressed a positive attitude towards a polypill intervention as primary prevention strategy with aspirin and calcium, providing some conditions are met. The most important conditions for implementation of such a strategy were safety, effectiveness and the possibility to make a well-informed autonomous decision.

Citing Articles

Barriers and facilitators of adherence to low-dose aspirin during pregnancy: A co-produced systematic review and COM-B framework synthesis of qualitative evidence.

Vinogradov R, Holden E, Patel M, Grigg R, Errington L, Araujo-Soares V PLoS One. 2024; 19(5):e0302720.

PMID: 38701053 PMC: 11068207. DOI: 10.1371/journal.pone.0302720.

Missed opportunity for aspirin prophylaxis for preeclampsia prevention: a cross-sectional study from Sub-Saharan Africa.

Sium A, Gudu W, Tolu L, Birara M, Bekele D AJOG Glob Rep. 2024; 4(1):100295.

PMID: 38205131 PMC: 10777106. DOI: 10.1016/j.xagr.2023.100295.

Factors affecting the implementation of calcium supplementation strategies during pregnancy to prevent pre-eclampsia: a mixed-methods systematic review.

Cormick G, Moraa H, Zahroh R, Allotey J, Rocha T, Pena-Rosas J BMJ Open. 2023; 13(12):e070677.

PMID: 38135336 DOI: 10.1136/bmjopen-2022-070677.

Psychological Impact and Women's Evaluation of the First-Trimester Pre-Eclampsia Screening and Prevention: ASPRE Trial.

Nikcevic A, Sacchi C, Marino C, OGorman N, Poon L, Nicolaides K Int J Environ Res Public Health. 2023; 20(7).

PMID: 37048032 PMC: 10094560. DOI: 10.3390/ijerph20075418.

Aspirin in the prevention of preeclampsia: A protocol for systematic review and meta analysis.

Mkhize P, Phoswa W, Khaliq O, Dorsamy V, Moodley J Medicine (Baltimore). 2022; 100(48):e27916.

PMID: 35049195 PMC: 9191338. DOI: 10.1097/MD.0000000000027916.

References

Levy V . Protective steering: a grounded theory study of the processes by which midwives facilitate informed choices during pregnancy. J Adv Nurs. 1999; 29(1):104-12. DOI: 10.1046/j.1365-2648.1999.00867.x. View

TUBIANA M . [The precautionary principle: advantages and risks]. J Chir (Paris). 2001; 138(2):68-80. View

Yusuf S . Two decades of progress in preventing vascular disease. Lancet. 2002; 360(9326):2-3. DOI: 10.1016/S0140-6736(02)09358-3. View

Scott P, Taylor A, Valimaki M, Leino-Kilpi H, Dassen T, Gasull M . Autonomy, privacy and informed consent 2: postnatal perspective. Br J Nurs. 2003; 12(2):117-27. DOI: 10.12968/bjon.2003.12.2.11051. View

Wensing M, Elwyn G . Methods for incorporating patients' views in health care. BMJ. 2003; 326(7394):877-9. PMC: 1125777. DOI: 10.1136/bmj.326.7394.877. View

Wald N, Law M . A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003; 326(7404):1419. PMC: 162259. DOI: 10.1136/bmj.326.7404.1419. View

Huizink A, Mulder E, Robles de Medina P, H A Visser G, Buitelaar J . Is pregnancy anxiety a distinctive syndrome?. Early Hum Dev. 2004; 79(2):81-91. DOI: 10.1016/j.earlhumdev.2004.04.014. View

Kornelsen J . Essences and imperatives: an investigation of technology in childbirth. Soc Sci Med. 2005; 61(7):1495-504. DOI: 10.1016/j.socscimed.2005.03.007. View

Duley L, Henderson-Smart D, Meher S, King J . Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007; (2):CD004659. DOI: 10.1002/14651858.CD004659.pub2. View

10.

Meads C, Cnossen J, Meher S, Juarez-Garcia A, Riet G, Duley L . Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess. 2008; 12(6):iii-iv, 1-270. DOI: 10.3310/hta12060. View

11.

Lewens T . The art of medicine. Taking sensible precautions. Lancet. 2008; 371(9629):1992-3. DOI: 10.1016/s0140-6736(08)60857-0. View

12.

Seefat-van Teeffelen A, Nieuwenhuijze M, Korstjens I . Women want proactive psychosocial support from midwives during transition to motherhood: a qualitative study. Midwifery. 2009; 27(1):e122-7. DOI: 10.1016/j.midw.2009.09.006. View

13.

Figueiredo B, Conde A . Anxiety and depression in women and men from early pregnancy to 3-months postpartum. Arch Womens Ment Health. 2011; 14(3):247-55. DOI: 10.1007/s00737-011-0217-3. View

14.

Blehar M, Spong C, Grady C, Goldkind S, Sahin L, Clayton J . Enrolling pregnant women: issues in clinical research. Womens Health Issues. 2013; 23(1):e39-45. PMC: 3547525. DOI: 10.1016/j.whi.2012.10.003. View

15.

Hibbard J, Greene J . What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health Aff (Millwood). 2013; 32(2):207-14. DOI: 10.1377/hlthaff.2012.1061. View

16.

Fleurence R, Selby J, Odom-Walker K, Hunt G, Meltzer D, Slutsky J . How the Patient-Centered Outcomes Research Institute is engaging patients and others in shaping its research agenda. Health Aff (Millwood). 2013; 32(2):393-400. DOI: 10.1377/hlthaff.2012.1176. View

17.

Souza E, Torloni M, Atallah A, Santos G, Kulay Jr L, Sass N . Aspirin plus calcium supplementation to prevent superimposed preeclampsia: a randomized trial. Braz J Med Biol Res. 2014; 47(5):419-25. PMC: 4075311. DOI: 10.1590/1414-431x20143629. View

18.

Wiley B, Fuster V . The concept of the polypill in the prevention of cardiovascular disease. Ann Glob Health. 2014; 80(1):24-34. DOI: 10.1016/j.aogh.2013.12.008. View

19.

Poon L, Nicolaides K . First-trimester maternal factors and biomarker screening for preeclampsia. Prenat Diagn. 2014; 34(7):618-27. DOI: 10.1002/pd.4397. View

20.

Bhutta Z, Das J, Bahl R, Lawn J, Salam R, Paul V . Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?. Lancet. 2014; 384(9940):347-70. DOI: 10.1016/S0140-6736(14)60792-3. View